Pre‐emptive antifungal therapy vs empirical antifungal therapy
Mortality ascribed to fungal infection · people with cancer who have febrile neutropenia
Pre‐emptive antifungal therapy showed no clear difference in mortality ascribed to fungal infection compared with empirical antifungal therapy (low certainty).
1 finding from 1 review
- Pre‐emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer 2022 · Cochrane Headline outcomes onlyRR 0.92 [0.45, 1.89]5 studies · 1407 participantsLow